How do you envision shaping the future of Bayer’s Consumer Health Division in your new role, and what are your priorities as you transition into these responsibilities?
My background gives me a unique perspective—I spent 15 years in Bayer's pharmaceutical business after starting my career in consumer health. This dual experience allows me to bring valuable insights into how healthcare innovation and accessibility can drive meaningful societal change. Moving into this role feels like coming home, and it’s energizing to reconnect with consumer health while leveraging lessons from both sectors.
At the Consumer Health division of Bayer, we have a deeply trusted global presence, reaching nearly 700 million people annually. Our products resonate universally, with many families relying on them to manage their health. Mothers, for example, often take the lead in choosing our solutions, reflecting a strong bond between our brands and consumers.
As we look to the future, we’re focused on expanding self-care accessibility, leveraging digital innovation, and ensuring that our solutions remain affordable and backed by our scientific heritage.
This vision—helping billions of people live healthier lives with the most trusted self-care solutions—is at the core of our strategy.
Do you see a tension or synergy between life sciences and consumer health, given your experience in both fields?
There’s an evolving synergy between the two fields, though they operate with distinct priorities. Consumer health emphasizes prevention and self care, offering solutions that empower people to manage their health proactively. Meanwhile, life sciences focus more on treatment and cure, addressing diseases when prevention is no longer sufficient. At Bayer, we see these as complementary rather than opposing forces, forming a continuum from prevention to cure.
This dual focus is shaping the consumer health industry, especially with pharmaceutical companies spinning off their consumer divisions, such as Kenvue (J&J), Haleon(GSK), and Opella (Sanofi). While consumer health involves over-the-counter products, which may be less regulated than pharmaceuticals, it demands responsibility and trust. At Bayer, we integrate prevention and treatment, offering solutions across the spectrum. For example, our investments in cell and gene therapies aim to revolutionize treatment, while our consumer health products empower individuals to take charge of their well-being, reflecting our holistic approach to healthcare.
How is Bayer responding to the exponential growth in interest in wellness and self-care?
The surge in well-being interest, accelerated by COVID-19, has reshaped the self-care landscape. During the pandemic, people sought ways to avoid hospitals and maintain health at home, driving demand for vitamins, multivitamins, and other self-care products. Digital commerce also played a pivotal role, with platforms like Amazon thriving as consumers turned to online shopping for health solutions.
Bayer’s strategy in this evolving landscape involves understanding consumer needs through advanced digital tools and leveraging AI to refine our offerings. We aim to make healthcare accessible, ensuring that our products meet the price-to-quality ratio consumers expect, especially in challenging economic times. By focusing on trust, innovation, and affordability, we’re not just adapting to change but actively driving it, with a particular emphasis on addressing unmet needs in areas like gut health, aging, and stress.
What role does innovation, particularly AI and digital tools, play in Bayer’s strategy for the future?
Innovation is central to Bayer’s vision, and we see AI and digital tools as transformative forces across our entire value chain. In R&D, cutting-edge AI technologies help catalyze the faster development of self-care solutions and improve how we manufacture and deliver innovation to our consumers.. In marketing, data-driven insights enable us to understand consumer behavior and preferences at an unprecedented scale. This shift empowers local teams to address specific needs quickly, cutting product development timelines in half.
We’ve also integrated AI into consumer health initiatives, such as our partnership with Huma on cardiovascular risk assessments and collaborations with Google on trend prediction. These technologies enhance our ability to personalize healthcare solutions and improve accessibility. By combining global capabilities with local insights, we’re ensuring that innovation happens where it’s most needed, making self-care solutions more effective and widely available.
What opportunities do you see in emerging markets like India and China for Bayer’s Consumer Health Division?
Emerging markets present immense potential for growth. In the U.S., per capita spending on self-care exceeds $100 annually, but in China, it’s around $12, and in India, it’s just $3. As the middle class in these countries grows and awareness of self-care increases, the potential to expand access and impact is enormous. Bayer is well-positioned to capture this growth by offering trusted, scientifically backed solutions that resonate with these emerging consumer bases.
Our approach involves tailoring innovation to local needs through agile R&D teams embedded in these regions. This proximity allows us to identify gaps, develop products faster, and meet the unique demands of these markets. By combining our global expertise with local insights, we’re creating sustainable growth while making healthcare more accessible worldwide.
How does Bayer balance its global strength with local innovation to meet diverse consumer needs?
Bayer’s strategy revolves around blending global strength with localized innovation. We maintain a significant global footprint, enabling us to leverage economies of scale and scientific expertise. Simultaneously, we empower local teams to innovate based on the specific needs of their markets. For example, our R&D personnel work closely with local communities to identify unmet needs and develop targeted solutions swiftly.
This model allows us to respond dynamically to market demands while maintaining a consistent standard of excellence. By integrating insights from global and local levels, we’re driving innovation that resonates universally, ensuring that our trusted brands continue to meet the evolving needs of consumers everywhere. This dual focus is key to our mission of making healthcare accessible, affordable, and effective for billions around the world.
